KALV
KalVista Pharmaceuticals, Inc. · Healthcare
CEO Benjamin L Palleiko sold $171K of KalVista Pharmaceuticals, Inc.
Sold$170,769
$12.01Price
14,215Shares
−6%Stake
What KALV did after the filing
- The stock from Thu, Aug 22 open, $12.48
- −9.0%
- S&P 500, same days
- +2.2%
Measured over 30 trading days, to the Oct 4 close.
Traded Mon, Aug 19. Filed Wed, Aug 21, 9:25 PM ET, after the close. Returns use the Aug 22 open and the Oct 4 close. Not investment advice.